Trademark: 97311053
Word
MEDILINKTHERA
Status
Registered
Status Code
700
Status Date
Tuesday, February 21, 2023
Serial Number
97311053
Registration Number
6986332
Registration Date
Tuesday, February 21, 2023
Mark Type
5000
Filing Date
Monday, March 14, 2022
Published for Opposition
Tuesday, December 6, 2022

Trademark Owner History

Classifications
5 Disinfectants; Pesticides; Anti-infective products for veterinary use; Cotton for medical purposes; Dental lacquer; Depuratives for the body; Disinfectant wipes; Gases and gas mixtures for medical imaging use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat and vegetables; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Sugar replacement for medicinal or therapeutic purposes; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Veterinary preparations, namely, pain relief medication
The mark consists of the stylized wording "MEDILINKTHERA".
MED LINK THERAPEUTICS
Color is not claimed as a feature of the mark.
The wording "MEDILINKTHERA" has no meaning in a foreign language.

Trademark Events
Feb 21, 2023
Notice Of Registration Confirmation Emailed
Feb 21, 2023
Registered-Principal Register
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Nov 1, 2022
Approved For Pub - Principal Register
Oct 28, 2022
Assigned To Examiner
Mar 18, 2022
New Application Office Supplied Data Entered
Mar 17, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24